Dalia Moawad, Executive Medical Director, Head of Scientific Strategy for Neurology, Ophthalmology, & Internal Medicine US Medical Affairs at Genentech
Advertisement
Articles by Dalia Moawad, Executive Medical Director, Head of Scientific Strategy for Neurology, Ophthalmology, & Internal Medicine US Medical Affairs at Genentech
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
POLARIS-AD Phase 3 Trial of PDE5 Inhibitor AR1001 Completes Treatment Phase With Favorable Safety Profile
2
FDA Accepts NDA for Apnimed’s AD109 for the Treatment of Obstructive Sleep Apnea
3
Phase 2 APPLAUDS Trial to Test Mivelsiran in Down Syndrome-Associated Alzheimer Disease
4
FDA Approves At-Home Starting Dose for Lecanemab, Marking First Subcutaneous Initiation Option for Alzheimer Disease Treatment
5